{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:30:34Z","timestamp":1787236234806,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is a common endocrinopathy which can be difficult to treat in adolescents. Fortunately, early identification and treatment can help mitigate some of the metabolic complications. In this review, we reflect on recent literature regarding PCOS diagnosis, associated complications, and treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Although there are three well known criteria to diagnose PCOS, they can be difficult to translate to adolescence. Newer diagnostic tools under study include anti-Mullerian hormone and revised ultrasound criteria. More is known about the many complications associated with PCOS, and new treatment options are on the horizon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>PCOS frequently will present during adolescence. These young women may already have symptoms of metabolic comorbidities. Providers caring for these patients must be aware of the many related complications and common treatment options. Newer diagnostic techniques and treatment options are under active study in adults, and may soon be translated to adolescence. A comprehensive approach allows treatment of patients\u2019 concerns, and also prevention of metabolic complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000636","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T21:51:37Z","timestamp":1526766697000},"page":"459-465","source":"Crossref","is-referenced-by-count":27,"title":["An update on PCOS in adolescents"],"prefix":"10.1097","volume":"30","author":[{"given":"Shannon","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"DiVasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Gooding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240108","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.fertnstert.2016.02.004","article-title":"Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome","volume":"105","author":"Kim","year":"2016","journal-title":"Fertil Steril"},{"key":"R2-20240108","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1542\/peds.2015-1430","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"136","author":"Rosenfield","year":"2015","journal-title":"Pediatrics"},{"key":"R3-20240108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2012.10.009","article-title":"Genetics of the polycystic ovary syndrome","volume":"373","author":"Kosova","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"R4-20240108","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.fertnstert.2012.08.025","article-title":"Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome","volume":"98","author":"Trottier","year":"2012","journal-title":"Fertil Steril"},{"key":"R5-20240108","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med"},{"key":"R6-20240108","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"R7-20240108","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome","author":"Zawadsky","year":"1992","journal-title":"Polycystic ovary syndrome"},{"key":"R8-20240108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R9-20240108","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20240108","article-title":"Do different diagnostic criteria cause impact polycystic ovary syndrome diagnosis for adolescents?","author":"Akg\u00fcl","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R11-20240108","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000375530","article-title":"The diagnosis of polycystic ovary syndrome during adolescence","volume":"83","author":"Witchel","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"R12-20240108","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R13-20240108","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fertnstert.2014.07.1241","article-title":"Utility of ultrasound in the diagnosis of polycystic ovary syndrome in adolescents","volume":"102","author":"Youngster","year":"2014","journal-title":"Fertil Steril"},{"key":"R14-20240108","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jadohealth.2017.09.005","article-title":"Ovarian morphology by transabdominal ultrasound correlates with reproductive and metabolic disturbance in adolescents with PCOS","volume":"62","author":"Rackow","year":"2018","journal-title":"J Adolesc Heal"},{"key":"R15-20240108","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-014-0300-6","article-title":"Antimullerian hormone as a diagnostic and prognostic tool for PCOS patients","volume":"31","author":"Wiweko","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"R16-20240108","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-M\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20240108","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.fertnstert.2016.10.009","article-title":"Antim\u00fcllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome","volume":"107","author":"Feldman","year":"2017","journal-title":"Fertil Steril"},{"key":"R18-20240108","first-page":"1175","article-title":"Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents","volume":"27","author":"Sopher","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R19-20240108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/cen.13358","article-title":"Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in anti-Muellerian hormone concentrations","volume":"87","author":"Reinehr","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R20-20240108","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000446111","article-title":"Do the anti-M\u00fcllerian hormone levels of adolescents with polycystic ovary syndrome, those who are at risk for developing polycystic ovary syndrome, and those who exhibit isolated oligomenorrhea differ from those of adolescents with normal menstrual cycles","volume":"85","author":"Savas-Erdeve","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"R21-20240108","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jadohealth.2016.10.015","article-title":"Anti-M\u00fcllerian hormone in obese adolescent girls with polycystic ovary syndrome","volume":"60","author":"Kim","year":"2017","journal-title":"J Adolesc Health"},{"key":"R22-20240108","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jpag.2016.07.001","article-title":"A review on glycosylated hemoglobin in polycystic ovary syndrome","volume":"29","author":"Rezaee","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R23-20240108","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2013.11.011","article-title":"Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors","volume":"173","author":"Shi","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R24-20240108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1358863X16682107","article-title":"Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers","volume":"22","author":"Patel","year":"2017","journal-title":"Vasc Med"},{"key":"R25-20240108","doi-asserted-by":"crossref","first-page":"122","DOI":"10.23736\/S0391-1977.16.02564-5","article-title":"Prevalence, etiology and management of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"42","author":"Makri","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"R26-20240108","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ijcp.12719","article-title":"Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment","volume":"69","author":"Spritzer","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"(Suppl 1)","key":"R27-20240108","first-page":"S14","article-title":"2018-ADA-standards-of-medical care in diabetes","volume":"41","author":"Riddle","year":"2018","journal-title":"J Clin Appl Res Educ"},{"key":"R28-20240108","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","author":"Whelton","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R29-20240108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and NASPGHAN","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R30-20240108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpag.2016.05.006","article-title":"Health-related quality of life in adolescents and young adults with polycystic ovary syndrome: a systematic review","volume":"29","author":"Kaczmarek","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R31-20240108","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/appi.ps.201200587","article-title":"Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death?","volume":"64","author":"Simon","year":"2013","journal-title":"Psychiatr Serv"},{"key":"R32-20240108","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pcl.2016.11.005","article-title":"Choosing the right oral contraceptive pill for teens","volume":"64","author":"Powell","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"R33-20240108","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"Br Med J"},{"key":"R34-20240108","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R35-20240108","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/1933719115623648","article-title":"Levonorgestrel-releasing intrauterine system for women with polycystic ovary syndrome","volume":"23","author":"Da Silva","year":"2016","journal-title":"Reprod Sci"},{"key":"R36-20240108","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"key":"R37-20240108","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/archdischild-2014-306471","article-title":"Optimal management of polycystic ovary syndrome in adolescence","volume":"100","author":"Baldauff","year":"2015","journal-title":"Arch Dis Childhood"},{"key":"R38-20240108","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humupd\/dmx012","article-title":"Prevalence of \u2018obesity-associated gonadal dysfunction\u2019 in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Escobar-Morreale","year":"2017","journal-title":"Hum Reprod Update"},{"key":"R39-20240108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1506699","article-title":"Weight loss and health status 3 years after bariatric surgery in adolescents","volume":"374","author":"Inge","year":"2016","journal-title":"N Engl J Med"},{"key":"R40-20240108","doi-asserted-by":"crossref","first-page":"434","DOI":"10.23736\/S0026-4946.17.04976-3","article-title":"Insulin sensitizers in adolescents with polycystic ovary syndrome","volume":"69","author":"Le","year":"2017","journal-title":"Minerva Pediatr"},{"key":"R41-20240108","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1570161114666161221115324","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of obese women with polycystic ovary syndrome","volume":"15","author":"Tzotzas","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"R42-20240108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07435800.2017.1294602","article-title":"Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved \u03b2-cell function and insulin sensitivity in metformin treated PCOS","volume":"42","author":"Jensterle","year":"2017","journal-title":"Endocr Res"},{"key":"R43-20240108","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0043-103573","article-title":"The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials","volume":"49","author":"Azadi-Yazdi","year":"2017","journal-title":"Horm Metab Res"},{"key":"R44-20240108","article-title":"Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study","author":"Yang","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"R45-20240108","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/09513590.2016.1250256","article-title":"Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients","volume":"33","author":"Karada\u011f","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"R46-20240108","doi-asserted-by":"crossref","first-page":"e20154089","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis","volume":"137","author":"Al Khalifah","year":"2016","journal-title":"Pediatrics"},{"key":"R47-20240108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10815-017-1047-7","article-title":"Polycystic ovary syndrome throughout a woman's life","volume":"35","author":"Bellver","year":"2018","journal-title":"J Assist Reproduct Genet"},{"key":"R48-20240108","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jadohealth.2017.04.010","article-title":"Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome","volume":"61","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"J Adolesc Heal"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201808000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:07:19Z","timestamp":1704686839000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201808000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000636","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}